CRISPR Therapeutics AG (CRSP)
125.69
-1.59 -1.25%
NASDAQ
Feb 26, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 0.719M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.29 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -348.86M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -28.93K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 9.481B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 11525.94 |
| PE Ratio | -- |
| Price to Book Value | 5.697 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -87.45M |
| Return on Equity | Upgrade |
View All CRSP News
News
-
WireHeadlineTime (ET)
-
Yahoo02/20 09:03
-
MT Newswires02/17 13:32
-
SA Breaking News02/17 08:52
-
MT Newswires02/17 08:47
-
Yahoo02/17 08:19
-
Yahoo02/17 08:18
-
Yahoo02/17 06:30
-
MT Newswires02/16 16:34
-
SA Breaking News02/16 16:18
-
MT Newswires02/16 16:03
-
Globe Newswire02/16 16:01
-
SA Breaking News02/16 14:25
-
Yahoo02/12 06:40
-
Yahoo02/11 09:01
-
Yahoo02/11 06:20
-
Yahoo02/11 00:51
-
Yahoo02/05 17:45
-
Yahoo02/05 09:32
-
Globe Newswire02/05 08:00
-
SA Breaking News02/05 06:58
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 04/28/2021 | Earnings | CRISPR Therapeutics AG First Quarter Earnings Results for 2021 |
| 02/16/2021 | Earnings | CRISPR Therapeutics AG Fourth Quarter Earnings Results for 2020 |
| 02/16/2021 | Misc | CRISPR Therapeutics AG Annual Report for 2020 |
| 10/28/2020 | Earnings | CRISPR Therapeutics AG Third Quarter Earnings Results for 2020 |
| 07/27/2020 | Earnings | CRISPR Therapeutics AG Second Quarter Earnings Results for 2020 |
| 06/11/2020 14:00 EDT | Misc | CRISPR Therapeutics AG Annual General Meeting for 2019 |
| 04/28/2020 | Earnings | CRISPR Therapeutics AG First Quarter Earnings Results for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.crisprtx.com
- Investor Relations URL: N/A
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Large Cap/Blend
- Next Earnings Release: Apr. 28, 2021
- Last Earnings Release: Feb. 16, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 125.69 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| ARKK | ARK Innovation ETF | 4.42% |
| MID326 | Global Healthcare Div F | 4.20% |
| ARKG | ARK Genomic Revolution ETF | 3.53% |
| ADNRX | American Beacon ARK Transfmt Innov R6 | 3.46% |
| IDNA | iShares Genomics Immnlgy & Hlthcr ETF | 3.37% |
| NEXTX | Shelton Green Alpha | 3.13% |
| PTH | Invesco DWA Healthcare Momentum ETF | 2.82% |
| GLO | Clough Global Opportunities | 2.11% |
| SIFZX | Sextant International Z | 2.06% |
| FRBRX | Franklin Biotechnology Discovery R6 | 1.40% |
| IBB | iShares Nasdaq Biotechnology ETF | 0.75% |
| TQAAX | T. Rowe Price QM US Small-Cap Gr Eq Adv | 0.67% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CRSP Tweets Stocktwits
Advertisement
